94 related articles for article (PubMed ID: 10491315)
1. Prevalence of circulating antibodies against a streptokinase C-terminal peptide in normal blood donors.
Ojalvo AG; Pozo L; Labarta V; Torréns I
Biochem Biophys Res Commun; 1999 Sep; 263(2):454-9. PubMed ID: 10491315
[TBL] [Abstract][Full Text] [Related]
2. A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.
Torréns I; Ojalvo AG; Seralena A; Pupo E; Lugo V; Páez R
Biochem Biophys Res Commun; 1999 Dec; 266(1):230-6. PubMed ID: 10581194
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and induction of circulating antibodies against recombinant staphylokinase.
Declerck PJ; Vanderschueren S; Billiet J; Moreau H; Collen D
Thromb Haemost; 1994 Jan; 71(1):129-33. PubMed ID: 8165631
[TBL] [Abstract][Full Text] [Related]
4. T-ceIl recognition of discrete regions of the thrombolytic drug streptokinase.
Lawley WJ; Fletcher S; Squire IB; Woods KL; Hewitt CR
Clin Sci (Lond); 2000 Sep; 99(3):239-46. PubMed ID: 11787478
[TBL] [Abstract][Full Text] [Related]
5. A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic.
Torrèns I; Ojalvo AG; Seralena A; Hayes O; de la Fuente J
Immunol Lett; 1999 Dec; 70(3):213-8. PubMed ID: 10656677
[TBL] [Abstract][Full Text] [Related]
6. Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection.
Blackwell N; Hollins A; Gilmore G; Norton R
J Clin Pathol; 2005 Sep; 58(9):1005-7. PubMed ID: 16126892
[TBL] [Abstract][Full Text] [Related]
7. A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments.
Reed GL; Kussie P; Parhami-Seren B
J Immunol; 1993 May; 150(10):4407-15. PubMed ID: 8482842
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy.
Torréns I; Reyes O; Ojalvo AG; Seralena A; Chinea G; Cruz LJ; de la Fuente J
Biochem Biophys Res Commun; 1999 May; 259(1):162-8. PubMed ID: 10334933
[TBL] [Abstract][Full Text] [Related]
9. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
[TBL] [Abstract][Full Text] [Related]
10. [Anti-streptokinase antibodies].
Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
[TBL] [Abstract][Full Text] [Related]
11. Should streptokinase be readministered? Insights from recent studies of antistreptokinase antibodies.
Cross DB
Med J Aust; 1994 Jul; 161(2):100-1. PubMed ID: 8028530
[No Abstract] [Full Text] [Related]
12. Complement activation reaches maximum during equilibrium between antigen and antibody in an in vitro model for thrombolysis with streptokinase.
Leinøe E; Pachaï A; Brandslund I
APMIS; 2000 Oct; 108(10):685-8. PubMed ID: 11200823
[TBL] [Abstract][Full Text] [Related]
13. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
14. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
Zhai P; Wakeham N; Loy JA; Zhang XC
Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
[TBL] [Abstract][Full Text] [Related]
15. Clinical and serological observations of streptococcal infection.
Fukushima H; Noumi T; Akamatsu Y; Kasagi M; Shimizu S
Yonago Acta Med; 1976 Apr; 20(1):50-4. PubMed ID: 1025927
[No Abstract] [Full Text] [Related]
16. Comparative study of the reactivity of natural and mutated streptokinase with total antistreptokinase antibodies in human sera.
Bandehpour M; Sharifnia Z; Mohajeri N; Taherkhani M; Koochaki A; Yarian F; Seyyed N; Shirvani R; Pakzad P; Saadat H; Kazemi B
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):734-8. PubMed ID: 23080363
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Helicobacter pylori infection among asymptomatic healthy blood donors in Northern Peninsular Malaysia.
Sasidharan S; Uyub AM
Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):395-8. PubMed ID: 19211121
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to syphilis among blood donors in Accra, Ghana.
Adjei AA; Kudzi W; Armah H; Adiku T; Amoah AG; Ansah J
Jpn J Infect Dis; 2003 Aug; 56(4):165-7. PubMed ID: 14583641
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
20. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study.
Zou S; Notari EP; Stramer SL; Wahab F; Musavi F; Dodd RY;
Transfusion; 2004 Nov; 44(11):1640-7. PubMed ID: 15504171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
